Tag: metastatic
American Urological Association recommends tumour ablation for kidney sparing
The American Urological Association (AUA), in partnership with the Society of Urologic Oncology (SUO), released the 2023 clinical practice guidelines for the diagnosis and...
Delcath Systems announces US FDA acceptance of Hepzato Kit new drug...
Delcath Systems has announced in a company press release that the US Food and Drug Administration (FDA) has accepted its (Delcath's) new drug application...
Delcath Systems announces updated results from CHOPIN phase 1b trial
Delcath Systems has shared in a press release the publication of updated results from the phase 1b CHOPIN Trial, conducted at Leiden University Medical...
An insight into treating liver tumours with thermal ablation
Amanda Smolock (Medical College of Wisconsin, Milwaukee, USA) discusses how her practice operates, using microwave ablation nearly exclusively for primary and metastatic liver tumours...
Ablation planning: “Interventional oncology must become reliable and reproducible”
Reto Bale (Medizinische Universität Innsbruck, Innsbruck, Austria) gave a presentation titled ‘Stereotactic thermal ablation—can it break the current limits?’ at the 2022 European Conference...
US FDA grants Breakthrough Therapy Designation for combination immunotherapy in HCC...
Roche has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab)...
